Back to search

Germany· DE-A57-03ed144cc2bd7a1f

Galantamin 1 A Pharma

A galantamine product containing galantamine, registered in Germany by 1 A Pharma Gmbh. The same ATC class is registered in 17 of our 19 countries.

ATC N06DA04

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedGalantamin 1 A PharmaATCN06DA04REGISTER NO.DE-A57-03ed144cc2bd7a…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Galantamine is registered in 17 of 19 countries.

Countries holding a registration under ATC N06DA04 (galantamine), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 10 of them publish a price we can compare per daily dose

Galantamine · ATC N06DA04

17 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of galantamine costs, country by country.

Normalised to the WHO defined daily dose (16 mg), the median price runs from $1.59 in Italy to $4.69 in Switzerland — a ×3.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Galantamine · price per daily dose (16 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.69
  • ES Spain$1.88
  • IT Italy$1.59
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Galantamine
Manufacturer
1 A Pharma Gmbh
Country
Germany (DE)
ATC code
N06DA04
ATC class
Galantamine
Defined daily dose
16 mg, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

237 interactions on record for galantamine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Galantamine · interactions on record

237 records

  • 8 severe
  • 202 moderate
  • 25 info

Most severe, free to view

  • OzanimodL04AA38severe
  • SiponimodL04AA42severe
  • OzanimodL04AE02severe
  • SiponimodL04AE03severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Galantamine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All galantamine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Galantamin Actavis, Galantamin Krka
  • Belgium · Reminyl
  • Bulgaria · Галантамин Дс, Галсия Sr
  • Denmark · Galantamin Krka, Galantamin Stada
  • Spain · Galantamina Aurovitas Spain, Galantamina Cinfa
  • Finland · Galantamin Krka, Galantamin Orion
  • France · Galantamine Lp Arrow Lab, Galantamine Lp Biogaran
  • United Kingdom (Northern Ireland) · Consion Xl, Gaalin
  • Greece · Aneprosil, Galantamine Pharmathen
  • Ireland · Galsya Sr
  • Iceland · Galantamin Stada
  • Italy · Galnora, Reminyl
  • Liechtenstein · Reminyl
  • Luxembourg · Reminyl, Reminyl (Emballage De Départ)
  • Latvia · Nivalin
  • Malta · Galantamine Syri Pharma
  • Netherlands · Bergal Sr, Galantamine Hydrobromide Aurobindo
  • Norway · Galantamin Krka, Reminyl
  • Poland · Nivalin
  • Portugal · Galantamina Azevedos, Galantamina Bluelife
  • Romania · Galsya, Reminyl
  • Sweden · Galantamin Actavis, Galantamin Krka
  • Slovenia · Galabar Sr, Galema Sr
  • Slovakia · Galantamin Viatris, Galsya Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ad10cda3-4e7e-470b-8d4f-f9b490a84a43
GET /v1/drugs/ad10cda3-4e7e-470b-8d4f-f9b490a84a43?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Galantamine",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about galantamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.